Stay updated on Dolutegravir Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Rilpivirine Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a citation regarding the efficacy, safety, and tolerability of dolutegravir-rilpivirine for HIV-1 maintenance therapy, which is a significant loss of core content.
    Difference
    0.1%
    Check dated 2025-05-07T20:11:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T18:00:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed study information regarding a clinical trial on HIV-1 treatment and the addition of collaborators and a new revision number.
    Difference
    20%
    Check dated 2025-04-16T12:59:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T05:42:14.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:42:19.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.4%
    Check dated 2025-02-24T20:24:43.000Z thumbnail image

Stay in the know with updates to Dolutegravir Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.